ED Beishuizen, JT Tamsma, JW Jukema, MA van … - Diabetes Care, 2005 - Am Diabetes Assoc OBJECTIVE—Cardiovascular disease (CVD) is the most important cause of mortality in patients
with type 2 diabetes and is preceded by endothelial dysfunction. Flow-mediated dilation
(FMD) is a noninvasive technique for measuring endothelial dysfunction. We aimed to ... Cited by 26 - Related articles - BL Direct - All 5 versions
W Tantikosoom, B Thinkhamrop, S Kiatchusakul, N … - J Med Assoc …, 2005 - medassocthai.org Page 1. J Med Assoc Thai Vol. 88 No.3 2005 399 Correspondence to : Tantikosoom
W, Queen Sirikit Heart Centre, Khon Kaen University, Khon Kaen 40002, Thailand.
Randomized Trial of Atorvastatin in Improving Endothelial ... Cited by 4 - Related articles - View as HTML - All 3 versions
K Bhargava, G Hansa, M Bansal, S Tandon, RR … - JAPI, 2003 - japi.org Aim of the Study : Endothelial function as assessed by brachial artery flow mediated vasodilatation
(FMD) has been shown to be impaired in patients with coronary artery disease (CAD). Since
diabetes mellitus (DM) has been considered to be CAD risk-equivalent, we sought to ... Cited by 10 - Related articles - View as HTML - BL Direct - All 3 versions
FV van Venrooij, MA van de Ree, ML Bots, RP Stolk … - Diabetes Care, 2002 - Am Diabetes Assoc OBJECTIVE—Endothelial dysfunction is considered an important early marker of atherosclerosis
and cardiovascular risk and is currently used as a surrogate end point for cardiovascular risk
in clinical trials. Type 2 diabetic patients show a characteristic dyslipidemia. Aggressive ... Cited by 66 - Related articles - BL Direct - All 6 versions
BM Balletshofer, S Goebbel, K Rittig, M … - … clinical endocrinology & …, 2005 - ncbi.nlm.nih.gov Disturbances in nitric oxide (NO) metabolism resulting in endothelial dysfunction play a central
role in the pathogenesis of atherosclerosis in hypercholesterolemia and in individuals with type
2 diabetes. It is unclear whether lipid lowering therapy with HMG-CoA-reductase ... Cited by 12 - Related articles - All 3 versions
A Nitenberg, I Pham, I Antony, P Valensi, JR Attali, D … - Atherosclerosis, 2005 - Elsevier Diabetes and arterial hypertension are major cardiovascular risk factors. Coronary endothelial
dysfunction is frequently observed in diabetic and hypertensive patients. This study was designed
to compare cardiovascular outcome of hypertensive (HT) and type 2 diabetic patients ... Cited by 14 - Related articles - All 13 versions
- ►diabetesjournals.org [PDF] WHH Sheu, YT Chen, WJ Lee - Diabetes Care, 2001 - Am Diabetes Assoc Animal studies have demonstrated lower levels of 1,25(OH)2D3 in a type 2 diabetes model compared
with controls (1). Alterations in circulat- ing vitamin D3 metabolites, such as de- creased 1-hydroxylase
activity and enhanced renal 25-hydroxylase activity, have been found in both ... Cited by 15 - Related articles - BL Direct - All 4 versions
[CITATION] Do statins lower blood pressure? evidence from the Anglo-Scandinavian Cardiac …
M Bosevski, V Borozanov, I Peovska, L Georgievska- … - Bratisl Lek Listy, 2007 - bratislmedj.sk University Institute for Heart Disease, Medical Faculty Skopje, Macedonia Address for
correspondence: Marijan Bosevski, MD, FICA, Vasil Gorgov 20/49 Skopje, Macedonia.
Phone: +389.23132373, Fax: +389.3164134 Acknowledgement: Paper is a part of a ... Cited by 2 - Related articles - All 5 versions
